- Home
- DIT vs ONCY Comparison
DIT vs ONCY Comparison
Compare DIT & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DIT
- ONCY
- Stock Information
- Founded
- DIT 1981
- ONCY 1998
- Country
- DIT United States
- ONCY Canada
- Employees
- DIT N/A
- ONCY N/A
- Industry
- DIT Food Distributors
- ONCY Pharmaceuticals and Biotechnology
- Sector
- DIT Consumer Discretionary
- ONCY Health Care
- Exchange
- DIT Nasdaq
- ONCY Nasdaq
- Market Cap
- DIT 78.7M
- ONCY 86.1M
- IPO Year
- DIT 1995
- ONCY 1999
- Fundamental
- Price
- DIT $126.13
- ONCY $0.79
- Analyst Decision
- DIT
- ONCY Strong Buy
- Analyst Count
- DIT 0
- ONCY 2
- Target Price
- DIT N/A
- ONCY $4.00
- AVG Volume (30 Days)
- DIT 296.0
- ONCY 2.4M
- Earning Date
- DIT 01-31-2025
- ONCY 03-06-2025
- Dividend Yield
- DIT 0.65%
- ONCY N/A
- EPS Growth
- DIT N/A
- ONCY N/A
- EPS
- DIT 7.15
- ONCY N/A
- Revenue
- DIT $2,141,481,108.00
- ONCY N/A
- Revenue This Year
- DIT N/A
- ONCY N/A
- Revenue Next Year
- DIT N/A
- ONCY N/A
- P/E Ratio
- DIT $17.64
- ONCY N/A
- Revenue Growth
- DIT 8.41
- ONCY N/A
- 52 Week Low
- DIT $118.25
- ONCY $0.71
- 52 Week High
- DIT $209.44
- ONCY $1.53
- Technical
- Relative Strength Index (RSI)
- DIT 44.44
- ONCY 38.26
- Support Level
- DIT $125.00
- ONCY $0.73
- Resistance Level
- DIT $135.70
- ONCY $0.86
- Average True Range (ATR)
- DIT 6.53
- ONCY 0.06
- MACD
- DIT -0.38
- ONCY -0.01
- Stochastic Oscillator
- DIT 5.89
- ONCY 20.33
About DIT AMCON Distributing Company
Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores, and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatment. The other projects in the company's pipeline include, Bracelet-1 for treatment of Breast Cancer, Goblet cohort-1, Goblet cohort-5 for treatment of Gastro-Intestinal Cancer among others.